ReviewActa neuropathologica communications2026
Immune niches in brain tumors: glial-immune cell interactions and spatial microdomains.
Review in Acta neuropathologica communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The immune microenvironment of brain tumors is characterized by remarkable diversity, where immune cells are not randomly distributed but are systematically organized into specific spatial microdomains. This spatial order is primarily orchestrated by glial cells, including astrocytes, microglia, and oligodendrocyte-lineage cells, which actively shape the local immune landscape by determining the position and activation states of infiltrating immune populations. To reflect the latest conceptual advances, this review first details the complex interaction networks through which glial cells directly modulate T-cell function and shape myeloid cell properties via cytokine signaling and metabolic regulation. We then examine how these active cellular communications synergize with the temporal process of tumor immunoediting and physical microenvironmental stressors (such as hypoxia) to drive the formation and physical anchoring of these immune niches. Consequently, these structurally established domains mature into functionally distinct, heavily immunosuppressive hubs that foster local T-cell exhaustion and coordinated immune escape. Because these niches are dynamically evolving ecosystems rather than static entities, they present profound architectural barriers, directly contributing to the heterogeneous and often limited responses to current immunotherapies. By integrating these spatial and temporal dynamics into a comprehensive conceptual framework, this review highlights the urgent clinical need to shift toward multidimensional, niche-disrupting therapeutic strategies, ultimately aiming to improve immunotherapy efficacy and clinical outcomes for patients with brain tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.